Exchange Traded Concepts »

Y Mabs Therapeutics shares owned by Exchange Traded Concepts

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Exchange Traded Concepts from 13F filings

Historical chart of Exchange Traded Concepts investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Exchange Traded Concepts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Exchange Traded Concepts

Quarter filed Position value Share count Share price at filing
2024-03-31 $309k 19k 16.26
2023-12-31 $192k 28k 6.82
2023-09-30 $114k 21k 5.45
2023-06-30 $110k 16k 6.79

More positions owned by Exchange Traded Concepts

Spdr Ser Tr Nuveen Bloomberg (HYMB)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds Real Estate Etf (VNQ)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Meta Platforms Cl A (META)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Qualcomm (QCOM)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Technology (XLK)
Williams Companies (WMB)

View all positions for Exchange Traded Concepts

Top funds holding Y Mabs Therapeutics

BlackRock
Paradigm Biocapital Advisors
Sofinnova Ventures
Vanguard Group
Point72 Asset Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Geode Capital Management
Acadian Asset Management
Caligan Partners
Soleus Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Boothbay Fund Management
Northern Trust

View all funds holding Y Mabs Therapeutics